Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinoma

Cancer Investigation

Volumn 28, Issue 9, 2010, Pages 896-903

  Fendri, Ali ^a   Khabir, Abdelmajid ^b   Hadri Guiga, Boutheina ^a   Sellami Boudawara, Tahia ^b   Daoud, Jamel ^b   Frikha, Mounir ^b   Ghorbel, Abdelmonem ^b   Gargouri, Ali ^a   Mokdad Gargouri, Raja ^a  

^a CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

^b HABIB BOURGUIBA HOSPITAL   (Tunisia)

Author keywords

Methylation specific PCR; Nasopharyngeal carcinoma; Reverse PCR; WIF 1; Wnt 5a

Indexed keywords

GLYCOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; WNT INHIBITORY FACTOR 1; WNT5A PROTEIN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER STAGING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; NOSE MUCOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SCHOOL CHILD; SIGNAL TRANSDUCTION; TUNISIA;

5' FLANKING REGION; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BASE SEQUENCE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTIVARIATE ANALYSIS; NASAL MUCOSA; NASOPHARYNGEAL NEOPLASMS; NASOPHARYNX; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TUNISIA; WNT PROTEINS; YOUNG ADULT;

EID: 77957986529     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2010.494324     Document Type: Article

References (51)

1. Nicholls, J. M.; Agathanggelou, A.; Fung, K.; Zeng, X.; Niedobitek, G. The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma. J Pathol 1997, 183, 164-168.
2. Busson, P.; Keryer, C.; Ooka, T.; Corbex, M. EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies. Trends Microbiol 2004, 12, 356-360.
3. Kammoun, M.; Vogt-Hoerner, G.; Mourali, N. Tumors of the nasopharynx in Tunisia: an anatomic and clinical study based on 143 cases. Cancer 1974, 33, 184-191.
4. Khabir, A.; Sellami, A.; Sakka, M.; Ghorbe, A. M.; Daoud, J.; Frikha, M.; Drira, M.; Busson, P.; Jlidi, R. Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas. Clin Cancer Res 2000, 6, 3932-3936.
5. Daoud, J.; Toumi, N.; Bouaziz, M.; Ghorbel, A. M.; Jlidi, R.; Drira, M.; Frikha M. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 2003, 39, 2349-2354.
6. Chang, E. T.; Hans-Olov, A. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 2006, 15, 335-339.
7. Feng, B. J.; Jalbout, M.; Ben Ayoub, W.; Khyatti, M.; Dahmoul, S.; Ayad, M.; Maachi, F.; Bedadra, W.; Abdoun, M.; Mesli, S.; Hamdi-Cherif, M.; Boualga, K.; Bouaouina, N.; Chouchane, L.; Benider, A.; Ben Ayed, F.; Goldgar, D.; Corbex, M. Dietary risk factors for nasopharyngeal carcinoma in Maghrebian countries. Int J Cancer 2007, 121, 1550-1555.
8. Lo, K. W.; To, K. F.; Huang, D. P. Focus on nasopharyngeal carcinoma. Cancer Cell 2004, 39, 2349-2354.
9. Jones, P. A.; Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3, 415-428.
10. Akiyama, T. Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 2000, 11, 273-282.
11. Seidensticker, M. J.; Behrens, J. Biochemical interactions in the Wnt pathway. Biochim Biophys Acta 2000, 495, 168-182.
12. Yamaguchi, T. P. Heads or tails: Wnts and anterior-posterior patterning. Curr Biol 2001, 11, 713-724.
13. Morin, P. J.; Sparks, A. B.; Korinek, V.; Barker, N.; Clevers, H. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275, 1787-1790.
14. Weeraratna, A. T.; Jiang, Y.; Hostetter, G.; Rosenblatt, K.; Duray, P.; Bittner, M.; Trent, J. M. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002, 58, 279-288.
15. Uematsu, K.; He, B.; You, L.; Xu, Z.; Mcormick, F.; Jablons, D. M. Activation of the Wnt pathway in non-small cell lung cancer: evidence of dishevelled overexpression. Oncogene 2003, 22, 7218-7221.
16. Lu, D.; Zhao, Y.; Tawatao, R.; Cottam, H. B.; Sen, M.; Leoni, L. M.; Kipps, T. J.; Corr, M. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2004, 101, 3118-3123.
17. Rhee, C. S.; Sen, M.; Lu, D.; Wu, C.; Leoni, L.; Rubin, J.; Corr, M. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 2002, 21, 6598-6605.
18. Lee, A. Y.; He, B.; You, L.; Dadfarmay, S.; Xu, Z.; Mazieres, J.; Mikami, I.; Cormick, F.; Jablons, D. M. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene 2004, 23, 6672-6676.
19. Holmen, S. L.; Salic, A.; Zylstra, C. R.; Kirschner, M. W.; Williams, B. O. A novel set of Wnt-frizzled fusion proteins identifies receptor components that activate beta-caten independent signaling. J Biol Chem 2002, 277, 34727-34735.
20. Nusse, R.; Varmus, H. E. Wnt genes and breast cancer. Cancer J Clin 1999, 49, 33-44.
21. Huang, C. L.; Liu, D.; Nakano, J.; Ishikawa, S.; Kontani, K.; Yokomise, H. Wnt-5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor-an expression in non-small cell lung cancer. J Clin Oncol 2005, 23, 8765-8773.
22. Lejeune, S.; Huguet, E. L.; Hamby, A.; Poulsom, R.; Harris, A. L. Wnt-5a cloning, expression, and upregulation in human primary breast cancers. Clin Cancer Res 1995, 1, 215-222.
23. Saitoh, T.; Mine, T.; Katoh, M. Frequent upregulation of Wnt-5A mRNA in primary gastric cancer. Int J Mol Med 2002, 9, 515-519.
24. Liang, H.; Chen, Q.; Coles, A. H.; et al. Wnt-5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 2003, 4, 349-360.
25. Blanc, E.; Roux, G. L.; Benard, J.; Raguenez, G. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma. Oncogene 2005, 24, 1277-1283.
26. Leris, A. C.; Roberts, T. R.; Jiang, W. G.; Newbold, R. F.; Mokbel, K. Wnt5A expression in human breast cancer. Anticancer Res 2005, 25, 731-734. (Pubitemid 40546838)
27. Kremenevskaja, N.; Wasielewski, R.; Rao, A. S.; Schofl, C.; Andersson, T.; Brabant, G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 2005, 24, 2144-2154.
28. Ying, J.; Li, H.; Yu, J.; Ka Man, Ng.; Poon, F. F.; Wong, S. C.; Chan, A. T. C.; Sung, J. J. Y.; Tao, Q. Wnt-5a exhibits tumor-suppressive activity through antagonizing the Wnt/B-catenin signaling, and is frequently methylated in colorectal cancer. Clin Cancer Res 2008, 14, 55-61.
29. Kawano, Y.; Kypta, R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 2003, 116, 2627-2634.
30. Hsieh, S. Y.; Hsieh, P. S.; Chiu, C. T.; Chen, W. Y. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 2004, 23, 9183-9189.
31. Suzuki, H.; Watkins, D. N.; Jair, K. W.; Schuebel, K. E.; Markowitz, S. D.; Chen, W. D.; Pretlow, T. P.; Yang, B.; Akiyama, Y.; Van Engeland, M.; Toyota, M.; Tokino, T.; Hinoda, Y.; Imai, K.; Herman, J. G.; Baylin, S. B. Epigenetic inactivation of SFRP genes allows constitutive Wnt signaling in colorectal cancer. Nat Genet 2004, 36, 417-422.
32. Kobayashi, K.; Ouchida, M.; Tsuji, T.; Heike, T.; Nakahata, T. Reduced expression of the REIC/Dkk-3 gene by promoterhypermethylation in human tumor cells. Gene 2002, 282, 151-158.
33. Hsieh, J. C.; Kodjabachian, L.; Rebbert, M. L.; Rattner, A.; Smallwood, P.; Samos, C. H.; Nusse, R.; Dawid, I. B.; Nathans, J. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 1999, 398, 431-436.
34. Mazieres, J.; He, B.; You, L.; Xu, K.; Kuchenbecker, D.; Raz, B.; Jablons, D. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res 2004, 64, 4717-7420.
35. Taniguchi, H.; Yamamoto, H.; Hirata, T. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers. Oncogene 2005, 24, 7946-7952.
36. Wissmann, C.; Wild, P. J.; Kaiser, S.; Roepcke, S.; Stoehr, R.; Woenckhaus, M.; Hartmann, A.; Knuechel, R.; Rosenthal, A.; Pilarsky, C. WIF-1, a component of the Wnt pathway, is downregulated in prostate, breast, lung, and bladder cancers. J Pathol 2003, 201, 204-212.
37. Chan, S. L.; Cui, Y.; van Hasselt, A.; Li, H.; Srivastava, G.; Jin, H.; Ng, K. M.; Wang, Y.; Lee, K. Y.; Tsao. G. S.; Zhong, S.; Robertson, K. D.; Rha, S. Y.; Chan, A. T.; Tao, Q. The tumor suppressor Wnt inhibitory factor1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Lab Invest 2007, 87, 644-650.
38. Zeng, Z. Y.; Zhou, Y. H.; Zhang, W. L.; Xiong, W.; Fan, S. Q.; Li, X.; Wu, M. H.; Yang, Y. X.; Huang, C.; Cao, L. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. Hum Pathol 2007, 38, 120-133.
39. Shi, W.; Bastianutto, C.; Li, A.; Perez-Ordonez, B.; Ng, R.; Chow, K. Y.; Zhang, W.; Jurisica, I.; Lo, K. W.; Bayley, A.; Kim, J.; O'Sullivan, B.; Siu, L.; Chen, E.; Liu, FF. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. Int J Cancer 2006, 119, 2467-2475.
40. Sobin, L. H.; Wittekind, C. H. International Union Against Cancer Classification and TNM Classification of Malignant Tumours, Ed. 5. New York: Wiley-Liss, 1997, 25-32.
41. Herman, J. G.; Graff, J. R.; Myo, H. S.; Nelkin, B. D.; Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996, 93, 9921-9926.
42. Palmisano, W. A.; Divine, K. K.; Saccomanno, G.; Gilliland, F. D.; Baylin, S. B.; Herman, J. G.; Belinsky, S. A. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60, 5954-5958.
43. Urakami, S.; Shiina, H.; Enokida, H.; Kawakami, T.; Tokizane, T.; Ogishima, T.; Tanaka, Y.; Ogishima, T.; Tanaka, Y.; Li, L. C.; Ribeiro Filho, L. A.; Terashima, M.; Kikuno, N. Epigenetic inactivation of Wnt Inhibitory Factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/βcatenin signaling pathway. Hum Cancer Biol 2006, 12, 383-391.
44. Reguart, N.; He, B.; Xu, Z.; You, L.; Lee, A. Y.; Mazieres, J. Cloning and characterization of the promoter of humain Wnt inhibitory factor-1. Biochem Biophys Res Commun 2004, 323, 229-234. (Pubitemid 39200673)
45. Livak, K. J.; Thomas, D. S. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δCT method. Methods 2001, 25, 402-408.
46. Chou, J.; Chou, M. S., Yu Ching, L.; Jae Kim, M. D.; Liang, Y.; Zhidong, Xu.; He, B.; David, M.; Jablons, B. Nasopharyngeal carcinoma, review of the molecular mechanisms of tumorigenesis. Clin Rev 2008, 10, 946-963.
47. Karim, R.; Tse, G.; Putti, T.; Richard, A.; Scolyer, C.; Soon, L. The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004, 36, 120-128.
48. Lin, Y. C.; You, L.; Xu, Z.; He, B.; Mikami, I.; Thunga, E.; Chou, J.; Kuchenbecker, K.; Kim, J.; Raz, D.; Yang, C. T.; Chen, J. K.; Jablons, D. M. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. BBRC 2005, 12, 635-640.
49. Khabir, A.; Karray, H.; Rodriguez, S.; Rose, M.; Daoud, J.; Frikha, M.; Boudawara, T.; Middeldorp, J.; Jlidi, R.; Busson, P. EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas. Virology J 2005, 39, 1-7.
50. Fendri, A.; Khabir, A.; Hdri-Guiga, B.; Sellami-Boudaouara, T.; Ghorbel, A.; Drira, M.; Daoud, J.; Frikha, M.; Gargouri, A.; Mokdad-Gargouri, R. Overexpression of COX-2 and LMP1 are correlated with lymph node in Tunisian NPC patients. Oral Oncol 2008, 44, 710-715.
51. Tsai, C. L.; Li, H. P.; Lu, Y. J.; Hsueh, C.; Liang, Y.; Chen, C. L.; Tsao, S. W.; Tse, K. P.; Yu, J. S.; Chang, YS. Activation of DNA methyltransferase 1 by EBV LMP1 involves c-Jun. NH (2)-terminal kinase signaling. Cancer Res 2006, 66, 11668-11676.